Morningside Venture Investments Ltd - Aug 15, 2023 Form 4 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role
10%+ Owner
Signature
/s/ Frances Anne Elizabeth Richard, Director
Stock symbol
AMLX
Transactions as of
Aug 15, 2023
Transactions value $
$0
Form type
4
Date filed
8/17/2023, 05:34 PM
Previous filing
Jul 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMLX Common Stock Gift $0 -2M -28.58% $0.00 5M Aug 15, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Morningside Venture Investments Ltd is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Reflects the gift / charitable donation of common stock to a 501(c)(3) non-profit organization. This is not a market transaction, thus no price has been reported. No value was received by the seller for the gifted shares.
F2 Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL and disclaim any personal beneficial ownership of any shares held by MVIL.